Home/Filings/4/0001654954-21-000347
4//SEC Filing

Jebsen Michael B 4

Accession 0001654954-21-000347

CIK 0000034956other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 5:02 PM ET

Size

5.2 KB

Accession

0001654954-21-000347

Insider Transaction Report

Form 4
Period: 2021-01-05
Jebsen Michael B
Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2021-01-05+70,00070,000 total
    Exercise: $1.85From: 2022-01-05Exp: 2031-01-05Common stock (70,000 underlying)

Issuer

TENAX THERAPEUTICS, INC.

CIK 0000034956

Entity typeother

Related Parties

1
  • filerCIK 0001481436

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:02 PM ET
Size
5.2 KB